Genpact Limited (NYSE:G) Shares Acquired by MassMutual Private Wealth & Trust FSB

MassMutual Private Wealth & Trust FSB increased its holdings in shares of Genpact Limited (NYSE:GFree Report) by 22.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,378 shares of the business services provider’s stock after purchasing an additional 619 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Genpact were worth $145,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in G. UMB Bank n.a. grew its holdings in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock worth $52,000 after purchasing an additional 433 shares during the last quarter. Aaron Wealth Advisors LLC grew its stake in Genpact by 8.0% during the 4th quarter. Aaron Wealth Advisors LLC now owns 7,437 shares of the business services provider’s stock worth $319,000 after buying an additional 548 shares during the last quarter. Kera Capital Partners Inc. acquired a new position in Genpact during the fourth quarter worth approximately $268,000. HB Wealth Management LLC lifted its stake in Genpact by 18.9% in the fourth quarter. HB Wealth Management LLC now owns 10,224 shares of the business services provider’s stock valued at $439,000 after buying an additional 1,627 shares during the last quarter. Finally, Wedge Capital Management L L P NC boosted its holdings in shares of Genpact by 6.5% in the fourth quarter. Wedge Capital Management L L P NC now owns 46,179 shares of the business services provider’s stock valued at $1,983,000 after acquiring an additional 2,830 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Genpact news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at approximately $11,926,218.40. The trade was a 4.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 35,058 shares of company stock worth $1,558,675 in the last quarter. Company insiders own 2.80% of the company’s stock.

Genpact Price Performance

Shares of NYSE G opened at $46.17 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85. Genpact Limited has a one year low of $30.23 and a one year high of $47.98. The firm has a market capitalization of $8.14 billion, a P/E ratio of 12.68, a PEG ratio of 1.52 and a beta of 1.18. The company’s fifty day moving average is $44.39 and its two-hundred day moving average is $40.02.

Genpact (NYSE:GGet Free Report) last issued its earnings results on Thursday, November 7th. The business services provider reported $0.75 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.04. Genpact had a net margin of 14.22% and a return on equity of 21.85%. The company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.19 billion. During the same period in the prior year, the business posted $0.67 earnings per share. Analysts forecast that Genpact Limited will post 2.95 EPS for the current fiscal year.

Wall Street Analyst Weigh In

G has been the subject of a number of recent research reports. TD Cowen increased their price target on shares of Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a research note on Friday, November 8th. Robert W. Baird upped their price objective on Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Needham & Company LLC lifted their target price on Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a research note on Monday, November 11th. Finally, Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and upped their price target for the stock from $44.00 to $55.00 in a research note on Tuesday. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Genpact currently has an average rating of “Hold” and an average target price of $44.00.

View Our Latest Stock Report on G

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.